<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/67B34D05-3A52-4A09-8FF9-F2398D60E246"><gtr:id>67B34D05-3A52-4A09-8FF9-F2398D60E246</gtr:id><gtr:name>University of Surrey</gtr:name><gtr:department>Microbial &amp; Cellular Sciences</gtr:department><gtr:address><gtr:line1>Registry</gtr:line1><gtr:line2>Stag Hill</gtr:line2><gtr:line4>Guildford</gtr:line4><gtr:line5>Surrey</gtr:line5><gtr:postCode>GU2 7XH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/67B34D05-3A52-4A09-8FF9-F2398D60E246"><gtr:id>67B34D05-3A52-4A09-8FF9-F2398D60E246</gtr:id><gtr:name>University of Surrey</gtr:name><gtr:address><gtr:line1>Registry</gtr:line1><gtr:line2>Stag Hill</gtr:line2><gtr:line4>Guildford</gtr:line4><gtr:line5>Surrey</gtr:line5><gtr:postCode>GU2 7XH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/6E7C5B2E-4543-45D9-A443-6E40F0A56361"><gtr:id>6E7C5B2E-4543-45D9-A443-6E40F0A56361</gtr:id><gtr:firstName>Johnjoe</gtr:firstName><gtr:surname>McFadden</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/47A5EBD9-E625-459B-B72E-1FF7482D1636"><gtr:id>47A5EBD9-E625-459B-B72E-1FF7482D1636</gtr:id><gtr:firstName>Claudio Adolfo</gtr:firstName><gtr:surname>Avignone-Rossa</gtr:surname><gtr:orcidId>0000-0002-1625-6487</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/DE8E1DE4-A599-4BD5-9EA9-3D80218CB507"><gtr:id>DE8E1DE4-A599-4BD5-9EA9-3D80218CB507</gtr:id><gtr:firstName>Michael</gtr:firstName><gtr:surname>Bushell</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/8DE1818A-4078-4086-A37D-C772A9A345E7"><gtr:id>8DE1818A-4078-4086-A37D-C772A9A345E7</gtr:id><gtr:firstName>Michael</gtr:firstName><gtr:otherNames>Henry</gtr:otherNames><gtr:surname>Beale</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/6FB25B0D-83B4-4C7B-B24D-2D5A306D5919"><gtr:id>6FB25B0D-83B4-4C7B-B24D-2D5A306D5919</gtr:id><gtr:firstName>Jane</gtr:firstName><gtr:surname>Ward</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/C90CDE46-355B-4EF9-BA07-00D9938CD172"><gtr:id>C90CDE46-355B-4EF9-BA07-00D9938CD172</gtr:id><gtr:firstName>Graham</gtr:firstName><gtr:otherNames>Roger</gtr:otherNames><gtr:surname>Stewart</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FD007208%2F1"><gtr:id>D231FBC2-A37A-4832-B5F6-A4B3B365D22E</gtr:id><gtr:title>Construction of a genome scale metabolic model of Mycobacterium tuberculosis to investigate growth-regulated modulation of metabolism.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/D007208/1</gtr:grantReference><gtr:abstractText>The TB bacillus is an important pathogen of man and animals that kills about three million people each year. This proposal is to develop a virtual model of the BCG vaccine strain of the TB bacillus in a computer. The model will provide important insight into how this pathogen grows and replicates. The model may also be used to perform virtual experiments that would be very hard or impossible to perform in the real world. For instance, it is difficult to study the behaviour of the TB bacillus when it is growing inside patient's lungs. But if we can identify the metabolic pathways that are active then we can perform easily virtual experiments that will, for instance, investigate how the bacillus will respond to a new antibiotic whilst it is living in the patient's lungs. The virtual TB may also be used to screen new compounds for activity against the TB bacillus: the effect of various antibiotics can be tested in the virtual TB cell far more quickly than with live cells (and with no possibility of the experimenter catching TB). But probably most importantly, the virtual TB cell can be used to invent new antibiotics, by identifying pathways, or groups of pathways, that are essential for growth. This model will first be built using DNA sequence data from the genome. However, to make the virtual cell more realistic, we must incorporate biological data. We will therefore grow the real life organism (actually the vaccine strain of the TB bacillus) in highly defined conditions in the laboratory and perform chemical analysis of what goes in and what comes out of the cell. A remarkable mathematical technique, known as metabolic flux analysis, can then be used to estimate the flux of metabolites through each central metabolism pathway inside the cell. This information will be incorporated into the virtual cell to make its behaviour correspond more closely with the biological organism. The next stage of the project is testing our virtual cell. To do this we will identify which pathways are essential in the virtual cell and then inactivate those pathways in living cells. We will then see if the growth (or absence of growth) of the real life cells matches the predictions of the model. These tests will be used to refine and improve the model that may thereafter be used in drug development.</gtr:abstractText><gtr:technicalSummary>The TB bacillus is an important pathogen of man and animals. New drugs are badly needed, particularly drugs that are effective against the persistent slow-growing form of the bacillus. However, very little is known concerning the physiological state of the tubercle bacillus during persistence. We have initiated a project to investigate Mycobacterium tuberculosis metabolomics for fast and slow growing cells and demonstrated differences in metabolism that may be relevant to persistence. This investigation is to further these findings and investigate the hypothesis that the tubercle bacillus modulates its metabolism in response to changes in growth rate. A genome-scale in silico M. tuberculosis model will initially be constructed using the genome annotation. Although useful, the model will be inadequate for in silico simulations, as information on the relative flux metabolites through each pathway cannot be extracted from genome data; and there are many orphan genes and genes with uncertain homology to genes of known function. We will therefore constrain the in silico model with (i) extracellular metabolite and macromolecular data to construct a central metabolism metabolic flux model; (ii) intracellular metabolite data to construct a more complete central metabolism flux model including parallel, divergent and bidirectional intracellular pathways. Metabolite levels will be measured at the MeTRO laboratory by a combination of biochemical and spectroscopy techniques including GC-MS, NMR-MS, LC-NMR and LC-MS. For intracellular metabolite measurements we will perform carbon-labelling experiments using 13C-labelled substrates. The model will be further interrogated by (i) targeted gene deletion and further flux measurements; (iii) whole genome transposon mutagenesis data indicating relative fitness of a library of mutants at both growth rates. The data will be integrated into the model to build a realistic full-scale metabolome/genome model of the TB bacillus at fast and slow growth rates. The model will be used to test the target hypothesis and may be further developed for drug development and analysis of transcriptome and metabolome data.</gtr:technicalSummary><gtr:fund><gtr:end>2009-06-18</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2006-01-19</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>435836</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>622845</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Investigation of stochastic variations in growth rate as the mechanism of drug tolerance in Mycobacterium tuberculosis</gtr:description><gtr:end>2015-04-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/J002097/1</gtr:fundingRef><gtr:id>8279453B-FE51-4495-9A11-CC4E165D672D</gtr:id><gtr:outcomeId>5ee522185ee5222c</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>405329</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Intracellular metabolism of Mycobacterium tuberculosis</gtr:description><gtr:end>2015-07-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>088677/Z/09/Z</gtr:fundingRef><gtr:id>3B3C7814-B3C4-40E2-911E-2817789B51F9</gtr:id><gtr:outcomeId>5ee15d365ee15d4a</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>142917</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC Small Grants - SurreyFBA: Interactive tool for computer simulations of genome scale metabolic networks.</gtr:description><gtr:end>2015-04-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/K015974/1</gtr:fundingRef><gtr:id>BE8F9924-461D-4E2D-BFEE-77A516E4B7C2</gtr:id><gtr:outcomeId>54635cf45c5dc7.66203220</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>51126</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Japan Partnering Award - Microbial Systems Biology</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/G530284/</gtr:fundingRef><gtr:id>A275FDEC-CF73-4CFC-AE11-24A9CC97949A</gtr:id><gtr:outcomeId>5ee4cb2e5ee4cb42</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-03-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>The principle outcome of this research was the construction of a genome-scale metabolic model of Mycobacterium tuberculosis. This has been used by many researchers, as evidenced by the 135 citations for the article describing this model. However, many other outputs of the project have also been extensively cited, such as our transcriptome analysis of growth-rat emodulation in mcycobacteria which has been cited 46 times.</gtr:description><gtr:firstYearOfImpact>2008</gtr:firstYearOfImpact><gtr:id>64F454C3-24C5-497E-A363-5FDDAB755AB1</gtr:id><gtr:impactTypes><gtr:impactType>Societal</gtr:impactType></gtr:impactTypes><gtr:outcomeId>5462e14cda4997.84895459</gtr:outcomeId><gtr:sector>Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>We constructed and paramerized a mathematical model of metabolism of the tubercle bacillus, Mycobacterium tuberculosis, the pathogen that causes tuberculosis in man and the closely-related pathogen, Mycobacterium bovis, which causes tuberculosis in livestock and wild animals.</gtr:description><gtr:exploitationPathways>The model and our findings have influenced other researchers, as evidenced by the fact that the publications arising from our grant have been cited more than 300 times. 
Our online metabolic model has also been used by many researchers to investigate metabolism of mycobacteria.</gtr:exploitationPathways><gtr:id>80BA009F-E5CB-49D0-A0AD-E49C46654F5B</gtr:id><gtr:outcomeId>54634e6b7c0d23.36618717</gtr:outcomeId><gtr:sectors><gtr:sector>Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors><gtr:url>http://sysbio3.fhms.surrey.ac.uk/</gtr:url></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>This is a FBA-based whole genome scale network representing M. tuberculosis metabolism</gtr:description><gtr:id>783E5B39-8EF0-4A41-ABB6-495E5B53F7EC</gtr:id><gtr:impact>the model has been used to study metabolism of M. tuberculosis, as evidenced by lareg number of citations to the model</gtr:impact><gtr:outcomeId>5463552a6445b3.55507115</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>GSMN-TB</gtr:title><gtr:type>Computer model/algorithm</gtr:type><gtr:url>http://sysbio3.fhms.surrey.ac.uk/</gtr:url><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>This model of metabolism of the meningitis pathogen Neisseria meningitidis, was developed using the approaches pioneered by development of our GSMN-TB model.</gtr:description><gtr:id>F81B57AD-F497-437E-99F5-36559E208AFB</gtr:id><gtr:impact>The paper describing the model has been cited several times, including a recent review on the metabolism and virulence of Neisseria meningitidis.</gtr:impact><gtr:outcomeId>546356f3b29ee9.29167268</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Metebolic model of Neisseria meningitidis Nmb_iTM560</gtr:title><gtr:type>Computer model/algorithm</gtr:type><gtr:url>http://sysbio3.fhms.surrey.ac.uk/</gtr:url><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>901C2982-86CD-4196-907E-98A4511427CE</gtr:id><gtr:title>Differential producibility analysis (DPA) of transcriptomic data with metabolic networks: deconstructing the metabolic response of M. tuberculosis.</gtr:title><gtr:parentPublicationTitle>PLoS computational biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8fd78506fa436f1017053e56897b2962"><gtr:id>8fd78506fa436f1017053e56897b2962</gtr:id><gtr:otherNames>Bonde BK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-734X</gtr:issn><gtr:outcomeId>doi_53d08008091d155a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>34C2601E-3652-4F6B-89A2-974BDE6EA1BB</gtr:id><gtr:title>Systems Biology of Tuberculosis</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a28e33f9136cc3ac23d2d131f8f129be"><gtr:id>a28e33f9136cc3ac23d2d131f8f129be</gtr:id><gtr:otherNames>McFadden, Johnjoe; Beste, Dany J.V.; Kierzek, Andrzej M.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:isbn>978-1-4614-4965-2</gtr:isbn><gtr:outcomeId>i_35014440253c067de0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D9F5159E-CD5B-4BFA-B30D-55FEFE96A117</gtr:id><gtr:title>The genetic requirements for fast and slow growth in mycobacteria.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/96d0a10adfd586cec49fbe8a8a3bb6cf"><gtr:id>96d0a10adfd586cec49fbe8a8a3bb6cf</gtr:id><gtr:otherNames>Beste DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>doi_53d080080c0d4684</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E1C046FB-9B86-481C-A7A1-251DC83023D8</gtr:id><gtr:title>Transcriptomic analysis identifies growth rate modulation as a component of the adaptation of mycobacteria to survival inside the macrophage.</gtr:title><gtr:parentPublicationTitle>Journal of bacteriology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/96d0a10adfd586cec49fbe8a8a3bb6cf"><gtr:id>96d0a10adfd586cec49fbe8a8a3bb6cf</gtr:id><gtr:otherNames>Beste DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0021-9193</gtr:issn><gtr:outcomeId>doi_53d0700709fed5d9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>34F1236B-50E1-414F-B4AC-A463BF2841F8</gtr:id><gtr:title>GSMN-TB: a web-based genome-scale network model of Mycobacterium tuberculosis metabolism.</gtr:title><gtr:parentPublicationTitle>Genome biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/96d0a10adfd586cec49fbe8a8a3bb6cf"><gtr:id>96d0a10adfd586cec49fbe8a8a3bb6cf</gtr:id><gtr:otherNames>Beste DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1474-7596</gtr:issn><gtr:outcomeId>doi_53d07c07c065eb37</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8970F78B-632A-4463-9143-6305865A2FFE</gtr:id><gtr:title>System-level strategies for studying the metabolism of Mycobacterium tuberculosis.</gtr:title><gtr:parentPublicationTitle>Molecular bioSystems</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/96d0a10adfd586cec49fbe8a8a3bb6cf"><gtr:id>96d0a10adfd586cec49fbe8a8a3bb6cf</gtr:id><gtr:otherNames>Beste DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1742-2051</gtr:issn><gtr:outcomeId>pm_53cbfd0bfd03e3ab9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>22991EF8-8985-4932-BCE8-5F9C598CEFCB</gtr:id><gtr:title>&amp;sup1;&amp;sup3;C metabolic flux analysis identifies an unusual route for pyruvate dissimilation in mycobacteria which requires isocitrate lyase and carbon dioxide fixation.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/96d0a10adfd586cec49fbe8a8a3bb6cf"><gtr:id>96d0a10adfd586cec49fbe8a8a3bb6cf</gtr:id><gtr:otherNames>Beste DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>doi_53d082082084754f</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/D007208/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>